Doryx coupon
Warner Chilcott Announces Approval of DORYX Delayed-Release 150 mg Tablets: Financial News - Yahoo! FinanceST. DAVID'S, Bermuda, June 23, 2008 (PRIME NEWSWIRE) -- Warner Chilcott Limited (NasdaqGS:WCRX - News) announced today that the Food and Drug Administration (FDA) has approved a 150 mg strength of DORYX(r) (doxycycline hyclate) Delayed-Release Tablets.DORYX Delayed-Release Tablets are a tetracycline-class oral antibiotic indicated for adjunctive treatment of severe acne. DORYX Delayed-Release Tablets contain enteric-coated pellets of doxycycline hyclate which do not release until they reach the small intestine, thereby minimizing the gastrointestinal side effects most commonly associated with other doxycycline products. The introduction of the 150 mg tablet strength to the existing DORYX Delayed-Release Tablets franchise of 100 mg and 75 mg offers greater dosing flexibility.